NCT02085590View on ClinicalTrials.gov

Effects of BCG on Immune Response

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2014

Conditions
Sepsis
Interventions
BIOLOGICAL

BCG vaccine

BIOLOGICAL

Lipopolysaccharide (LPS) E. Coli 1 ng/kg intravenously

Trial Locations (1)

6525 GA

Radboud University Medical Centre, Intensive Care, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02085590 - Effects of BCG on Immune Response | Biotech Hunter | Biotech Hunter